Copaxone and Vitamin e drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Copaxone (glatiramer acetate) and Vitamin e (tocopherols and tocotrienols). Common drug interactions include arthralgia among females and memory impairment among males.
The phase IV clinical study analyzes what interactions people have when they take Copaxone and Vitamin e. It is created by eHealthMe based on reports of 297 people who take the same drugs from the FDA, and is updated regularly.
What is Copaxone?
Copaxone has active ingredients of glatiramer acetate. It is often used in multiple sclerosis. eHealthMe is studying from 56,931 Copaxone users. Check the latest studies of Copaxone.
What is Vitamin e?
Vitamin e has active ingredients of tocopherols and tocotrienols. It is often used in vitamin supplementation. eHealthMe is studying from 42,279 Vitamin e users. Check the latest studies of Vitamin e.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
297 people who take Copaxone and Vitamin e together, and have interactions are studied.
What are the common drug interactions of Copaxone and Vitamin e, by gender? *
What are the common drug interactions of Copaxone and Vitamin e, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Copaxone and Vitamin e?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Copaxone and Vitamin e:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Copaxone:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Vitamin e:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Copaxone and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Vitamin e and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Michaud CJ, Bockheim HM, Nabeel M, Daum TE, "Diagnosis of Exclusion: A Case Report of Probable Glatiramer Acetate-Induced Eosinophilic Myocarditis", Case reports in neurological medicine, 2014 Jul .
- Michaud CJ, Bockheim HM, Nabeel M, Daum TE, "Diagnosis of Exclusion: A Case Report of Probable Glatiramer Acetate-Induced Eosinophilic Myocarditis", Case reports in neurological medicine, 2014 Jul .
How the study uses the data?
The study uses data from the FDA. It is based on glatiramer acetate and tocopherols and tocotrienols (the active ingredients of Copaxone and Vitamin e, respectively), and Copaxone and Vitamin e (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Clobetasol Propionate and Tacrolimus drug interactions for girls aged 10-19 - 9 seconds ago
- Lisinopril and Metastatic Renal Cell Carcinoma for Women aged 60+ - 16 seconds ago
- Amoxil and Reglan drug interactions for women aged 40-49 - 22 seconds ago
- Fentanyl and Multiple Sclerosis Relapse for Women aged 40-49 - 23 seconds ago
- Could Tamoxifen Citrate cause Hand Deformity? - 33 seconds ago
- Ortho Tri-Cyclen and Proctitis Ulcerative for Women aged 20-29 - 36 seconds ago
- Azathioprine and Speech Impairment (Adult) for Men aged 60+ - 43 seconds ago
- Azathioprine and Slurred Speech for Men aged 60+ - 43 seconds ago
- Azathioprine and Language Impairment for Men aged 60+ - 44 seconds ago
- Azathioprine and Inability To Speak for Men aged 60+ - 44 seconds ago